Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-04-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
第六届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 华邦生命健康股份有限公司 regarding their meeting held on April 26, 2018. It includes approvals of various reports such as the 2017 Supervisory Board Work Report, 2017 Financial Statements, 2017 Profit Distribution Plan, 2017 Annual Report and its summary, audit opinions on the 2017 Annual Report, internal control self-evaluation report, and the 2018 first quarter report. The document also mentions that these reports will be submitted to the 2017 Annual General Meeting for approval. The document is a formal announcement of the meeting resolutions and approvals rather than the reports themselves. It is relatively short (1981 characters) and serves as an official disclosure of meeting decisions. Therefore, it fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not contain the full reports or detailed financial data itself.
2018-04-27 Chinese
“15华邦债”2018年第一次债券持有人会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution of a bondholders' meeting for the '15 华邦债' bond issued by 华邦生命健康股份有限公司. It details the meeting's basic information, attendance, voting results, and legal opinion on the meeting's validity. The document does not contain financial statements or detailed financial data but rather reports on the outcome of a specific bondholders' meeting. This fits the category of a Regulatory Filing (RNS) as it is a formal announcement related to corporate governance and bondholder decisions but not a full financial report or other specific filing types like capital updates or management changes.
2018-04-18 Chinese
“14华邦01”2018年第一次债券持有人会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the resolution of a bondholders' meeting for a specific bond issuance ('14 华邦01'). It details the meeting's basic information, attendance, voting results, and legal opinions confirming the meeting's compliance with relevant laws and regulations. The document does not contain financial statements or detailed financial analysis but rather reports on the outcome of a bondholders' meeting and related legal opinions. This fits the category of a Regulatory Filing (RNS) as it is a formal announcement related to regulatory compliance and meeting outcomes, not a full financial report or other specific filing type.
2018-04-18 Chinese
2014年公司债券（第一期）临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a "临时受托管理事务报告" which translates to "Interim Trustee Management Affairs Report" for a 2014 company bond issuance by Huapont Life Sciences Co., Ltd. It contains detailed information about the bond issuance, terms, a significant event (share repurchase and capital reduction), trustee's duties, and risk warnings. The document is prepared by the bond trustee (Southwest Securities) and includes financial data and analysis related to the bond and the issuer's financial condition. It is not a full annual or interim financial report but a specific report related to bond trustee management activities and bondholder interests. This fits the category of an Audit Report / Information (AR) as it is a standalone report related to bond management and compliance, not a full annual report or earnings release. The document length (6579 characters) and detailed content support this classification rather than a brief announcement or regulatory filing. Therefore, the filing type is AR with high confidence. 9M 2017
2018-04-18 Chinese
北京市时代九和律师事务所关于公司“14华邦01”2018年第一次债券持有人会议的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and proceedings of a bondholders' meeting for a specific bond issuance ("14华邦01") of Huabang Life Health Co., Ltd. It details the legal compliance of the meeting's call, attendance, voting procedures, and results. The document does not contain financial statements or management discussion but is a legal opinion related to a bondholders' meeting. It is not an annual report, audit report, earnings release, or any financial report. It is also not a simple announcement but a legal opinion letter. This type of document fits best under Regulatory Filings (RNS) as it is a legal compliance document related to corporate bondholder meetings and does not fit other more specific categories.
2018-04-18 Chinese
2015年公司债券临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2015 Company Bond Temporary Trustee Management Affairs Report" for Huapont Life Sciences Co., Ltd. It is prepared by the bond trustee (Southwest Securities Co., Ltd.) and includes detailed information about the bond issuance, bond terms, bondholder meetings, and trustee activities. The content focuses on bond management, bondholder meetings, bond repurchase plans, and risk warnings related to the bond. It is not a full annual or interim financial report, nor is it an earnings release or investor presentation. It is a specialized report related to bond trustee management and bondholder affairs, which fits the category of Audit Report / Information (AR) as it involves regulatory compliance, bond trustee duties, and bondholder meeting results. The document length (6778 characters) and detailed content confirm it is a full report, not just an announcement. Therefore, the appropriate classification is AR (Audit Report / Information). Q3 2017
2018-04-18 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.